• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Xyntek Partners with Nymi, Adding Wearable Biometric Devices to Their Biometric Authentication Platform

Share:

December 2, 2019

Nymi Bands enable biometric authentication and e-signatures

Xyntek Incorporated, a global leader in pharmaceutical and life sciences automation and IT solutions recently signed a partnership agreement with Nymi, expanding our Turnkey Biometrics Authentication Platform to include wearable technology. Nymi Bands join an already impressive list of iris and fingerprint scanning technologies that Xyntek integrates to business-critical operations and processes. These solutions bring significant improvements and efficiencies to complex and GxP controlled laboratory, manufacturing, and healthcare processes that require user authentication and electronic signatures to review/approve completion of critical process steps. Nymi’s unique wearable authentication solution, activated by a user’s biometrics, keeps workers continuously authenticated to facilitate rapid logins/e-signatures with just a tap of their wrist.

Xyntek’s platform is built around a high-availability centralized authentication service which transforms a user’s biometric identity into their enterprise account credentials in seconds. Xyntek’s biometric platform supports all standard biometric devices including fingerprints and iris scanners, and our new partnership will add wearable technology, Nymi Bands, to the platform.

Xyntek’s complete biometric solution installed on a mobile workstation

Mac Hashemian, P.E., CEO of Xyntek explains, “In the past a user’s identity was verified based on what we know, such as our username/passwords/PINs or what we have, such as ID & access cards. Biometric authentication enables user identification based on who we are, by using unique physical characteristics such as iris patterns and fingerprints to allow access to extremely sensitive systems, information and/or environments. With digital transformation and the push for mobility, we now have to factor in “what extends us” to this equation. The Nymi Biometric wearable technology provides an additional level of flexibility that provides operators with a more efficient way to achieve compliance and security without compromising productivity.”

Nymi’s Vice President, Andrew Foxcroft adds,”We are excited to be working closely with Xyntek and integrating the Nymi Bands into Xyntek’s portfolio of solutions and services. There are many use cases in the Life Sciences GxP environments that can benefit from wearable authentication devices. By combining our technology with Xyntek’s Biometric Authentication Platform, we can address a number of important use cases featuring enterprise authentication that delivers data integrity and security, allowing highly regulated industries to achieve compliance and productivity.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Bvi® Acquires Benz Research & Development, Strengthening End to End Iol Design, Production and Sales CapabilitiesBvi® Acquires Benz Research & Development, Strengthening End to End Iol Design, Production and Sales Capabilities
  • Alkermes Buys Rodin Therapeutics to Bolster Cns Pipeline in $950 Million DealAlkermes Buys Rodin Therapeutics to Bolster Cns Pipeline in $950 Million Deal
  • Chinese Startup CareVoice Officially Launches CareVoiceOSChinese Startup CareVoice Officially Launches CareVoiceOS
  • Haleon and Microsoft Partner to Help Users Who are Blind or Low Vision Lead More Independent LivesHaleon and Microsoft Partner to Help Users Who are Blind or Low Vision Lead More Independent Lives
  • Mission Bio Announces and Launches Single-Cell Measurable Residual Disease (MRD) AssayMission Bio Announces and Launches Single-Cell Measurable Residual Disease (MRD) Assay
  • Battelle Brings Specialized Engineering Capabilities and Clinical Study Expertise to Collaboration with Spark Biomedical on Department of Defense $1.15 Million GrantBattelle Brings Specialized Engineering Capabilities and Clinical Study Expertise to Collaboration with Spark Biomedical on Department of Defense $1.15 Million Grant
  • Ipsen Snags Epizyme and Cancer Portfolio for a Cool $247MIpsen Snags Epizyme and Cancer Portfolio for a Cool $247M
  • Takeda gets key U.S. regulatory approval to buy ShireTakeda gets key U.S. regulatory approval to buy Shire

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications